Management
 |
Jeff Zonderman, Chief Executive Officer Jeff brings over 30 years’ experience in sales, marketing, business development and general management leadership within the mass spec and analytical tools space. Before joining IonSense, Jeff played key roles in the advancement of new technology platforms and their commercialization at companies such as Waters, Cohesive Technologies, Thermo Fisher Scientific, Quad Technologies and RedShiftBio |
 |
Brian Musselman, Chief Technical Officer Before joining IonSense, Dr. Musselman played a key role in the advancement of new and higher performance analytical instruments at instrument vendors JEOL and Applied Biosystems (PerSeptive) before moving to consulting for notable startups such as Advion, MassTech, Syagen, BioInquire and MicroPhage. He holds a Ph.D. in Biochemistry from Michigan State University. |
 |
Douglas Simmons, Vice President of Operations Since the founding of IonSense, Mr. Simmons has been a key contributor to every DART® product development and manufacturing effort during the company’s expansion and steady growth. Mr. Simmons is responsible for all production, quality, service, and installations. He earned a BS in Mechanical Engineering from Tufts University. |
|
|
Board of Directors
 |
Bob Linke, Executive Chairman Mr. Linke currently serves as CEO Embera NeuroTherapeutics Inc. His 30 years of healthcare experience includes leadership roles developing and commercializing products at both public companies, Baxter International and Caremark International, and as an entrepreneur leading private equity-backed companies, including Periodontix, a biotech company, Rapid Micro Biosystems, a diagnostic company, and Embera, raising over $65 million in private equity and non-dilutive financing to build and fund these companies. He received his MBA from Harvard Business School and serves as an Adjunct Professor for Brown University’s Executive Masters in Healthcare Leadership Program. |
|
Brian Musselman Before joining IonSense, Dr. Musselman played a key role in the advancement of new and higher performance analytical instruments at instrument vendors JEOL and Applied Biosystems (PerSeptive) before moving to consulting for notable startups such as Advion, MassTech, Syagen, BioInquire and MicroPhage. He holds a Ph.D. in Biochemistry from Michigan State University. |
 |
Bruce Lehman As co-founder and CEO of LehmanMillet, Mr. Lehman led the organization which became the nation's leading medical marketing services firm dedicated to helping innovator companies change the standard of care. Bruce retired from LehmanMillet at the end of 2013. He is a member of the Board of Directors of the nonprofit organization Gosnold of Cape Cod, one of the leading addiction treatment organizations in the United States and a former member of the Board of Directors of LifeBox U.S., a non-profit founded by Dr. Atul Gawande and the British Society of Anesthesiology whose mission is to make surgery safer in the third world.
|
 |
Michael Kersker Dr. Kersker, a Founder of IonSense, served as the Vice President and Member of the Board of JEOL USA, President of Electroscan Corp., sold to Philips Electronics, and President of Magnotix. He is also a member of the Alumni Advisory Board, University of Florida and the Board of Directors of the Microscopy Society of America. He received a Ph.D. from the University of Florida. |
 |
William Adam Hill Dr. Hill is currently a founder and the CTO at Triple Sharp Venture Engineering. His 20 years in pharmaceutical research includes time at Schering Plough and Millennium before moving to the Novartis Institutes for BioMedical Research where he was a Director and Head of Screening. He led the integration of mass spectrometry into early drug discovery and the development of an ultra-high throughput screening mass reader He received his D.Phil. in Chemistry from the University of Oxford, UK. |
